Research ArticleNuclear Oncology
In Vivo Hybridization of Technetium-99m-Labeled Peptide Nucleic Acid (PNA)
G. Mardirossian, K. Lei, M. Rusckowski, F. Chang, T. Qu, M. Egholm and D.J. Hnatowich
Journal of Nuclear Medicine June 1997, 38 (6) 907-913;
G. Mardirossian
K. Lei
M. Rusckowski
F. Chang
T. Qu
M. Egholm
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vivo Hybridization of Technetium-99m-Labeled Peptide Nucleic Acid (PNA)
G. Mardirossian, K. Lei, M. Rusckowski, F. Chang, T. Qu, M. Egholm, D.J. Hnatowich
Journal of Nuclear Medicine Jun 1997, 38 (6) 907-913;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Preparation and Evaluation of 99mTc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors
- Amplification Targeting: A Modified Pretargeting Approach with Potential for Signal Amplification--Proof of a Concept
- Tumor Pretargeting in Mice Using 99mTc-Labeled Morpholino, a DNA Analog
- In Vitro Investigations of Tumor Targeting with 99mTc-Labeled Antisense DNA
- Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression